profit from every $100 of sales.
$0$100
SeaStar Medical
$1.92+1.05% today
-60.8% in 1 year
1-year low $1.881-year high $5.08
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2024 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What SeaStar Medical sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $1.23 million in 2025, with -$12.2 million of profit last year.
SalesProfit
SeaStar Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| SeaStar Medical | No profit yet | ||
 Vertex Pharmaceuticals | 35.1× · Expensive | ||
 Moderna | No profit yet | ||
 Regeneron Pharmaceuticals | 22.0× · Fair price | ||
 CSL | 22.1× · Fair price |
AI analysis
An AI analyst reads SeaStar Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 1 | |
| – | 0 | 0 | 1 | |
| -12 | -14 | -18 | -12 | |
| -12 | -25 | -25 | -12 | |
| -12 | -26 | -25 | -12 | |
| -700.00 | -302.60 | -66.30 | -5.86 | |
| – | – | 100.0% | 95.7% | |
| – | – | -13,216.3% | -986.6% | |
| – | – | -18,392.6% | -984.6% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3 | 4 | 5 | 14 |
| Cash | 0 | 0 | 2 | 12 |
| Total debt | 9 | 9 | 1 | 1 |
| Total liabilities | 24 | 17 | 7 | 4 |
| -21 | -14 | -2 | 10 | |
| 0 | 0 | 0 | 2 | |
| – | – | – | -87.5% | |
| 58.7% | 189.1% | 1,137.4% | -116.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -8 | -10 | -16 | -14 | |
| – | – | – | – | |
| -8 | -10 | -16 | -14 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 1 | 2 | 1 | 1 |
Valuation
- –
- –
- –
- 20.1×
- 8.3×
- –
- –
- -133.2%
- -119.0%
- 0.0%
Profitability
- 95.7%
- -986.6%
- -984.6%
- -832.3%
- -156.3%
- 890.2%
- -146.3%
- -105.6%
- -163.4%
- 517.5%
Growth
- +814.1%
- –
- +15.0%
- –
- +346.5%
Financial health
- -0.9×
- 0.05
- 2.9%
- -36.7×
- 2.73
- 2.71
- 0.13
What analysts expect
- Average price target
- $6.00
- Range
- $6.00 – $6.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | -0.90 | -0.73 | −23.3% |
| Mar 25, 2026 | -0.80 | -0.97 | +17.5% |
| Nov 13, 2025 | -1.30 | -1.50 | +13.3% |
| Aug 13, 2025 | -0.18 | -0.43 | +58.1% |
| May 14, 2025 | -0.44 | -0.52 | +15.4% |
| Mar 27, 2025 | -0.90 | -0.89 | −1.1% |
| Nov 13, 2024 | -1.10 | -1.13 | +2.7% |
| Aug 13, 2024 | -1.03 | -1.41 | +27.0% |
News
Seastar Medical anticipates NEUTRALIZE-AKI enrollment completion by midyear 2027 while preparing modular PMA submissionsSeeking Alpha · Nov 11, 2026Icu Medical signals 2026 results toward high end of $415M-$435M EBITDA and $8.60-$9 EPS range as logistics consolidation normalizesSeeking Alpha · Nov 5, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/6Passes 3 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
54No pass
Benjamin Graham
44No pass
Philip Fisher
67Pass
Peter Lynch
–Not enough data
Joel Greenblatt
4No pass
Charlie Munger
81Pass
Terry Smith
77Pass
Questions about SeaStar Medical
Is SeaStar Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 3 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the SeaStar Medical AI analysis
What does SeaStar Medical do?
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. It is in Biotechnology.
Does SeaStar Medical pay a dividend?
No. SeaStar Medical does not pay a dividend at the moment.
Is SeaStar Medical stock halal?
No. SeaStar Medical does not pass our halal screen: its cash and confirmed interest-bearing investments are 117% of its market value, at or above the 33% limit. How we check
How has SeaStar Medical stock done over the past year?
Down 60.8% over the past twelve months, to $1.92. It traded between $1.88 and $5.08 and is 62.2% below its high.
Who are SeaStar Medical's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals and CSL. The peers table on this page compares their profit, growth and price with SeaStar Medical's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.